NF-kappaB-IN-10 (compound E1) is an NF-kappaB inhibitor that mitigates heart failure symptoms by modulating the Nrf2/NF-kappaB signaling pathway, alleviating oxidative stress and inflammation. It suppresses LPS-induced NO production and downregulates iNOS and COX-2 expression in RAW264.7 cells, showing potential for cardiovascular disease research [1].
Molekulargewicht:
434.53
Formel:
C26H30N2O4
Target-Kategorie:
NF-kappaB
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
